Global Abortion Drugs Market to Exceed USD 54.27 Billion by 2033 | CAGR of 8.09%
Category: HealthcareGlobal Abortion Drugs Market to Exceed USD 54.27 Billion by 2033
According to a research report published by Spherical Insights & Consulting, the Global Abortion Drugs Market Size Expected to Grow from USD 24.92 Billion in 2023 to USD 54.27 Billion by 2033, at a CAGR of 8.09% during the forecast period 2023-2033.
Get more details on this report -
Browse 210 market data Tables and 45 Figures spread through 190 Pages and in-depth TOC on the" Global Abortion Drugs Market Size, Share, and COVID-19 Impact Analysis, By Drug Class (Mifepristone, Misoprostol, Pitocin, Hemabate, and Carboprost), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here:https://www.sphericalinsights.com/reports/abortion-drugs-market
Abortion is the process of ending a pregnancy by removing the embryo, fetus, and placenta from the uterus using medication or surgery. Abortion medications such as mifepristone and misoprostol also provide a safe and dependable way to terminate a pregnancy. Additionally, the progesterone hormone promotes a pregnancy's natural growth; hence, mifepristone abortion medicine is used to counteract its effects. When progesterone hormones are blocked, the uterine lining deteriorates, ending the pregnancy. After taking mifepristone, the doctor also suggests taking misoprostol, a second abortion drug that causes cramping and bleeding to empty the uterus. Furthermore, the rise in abortions is driving up demand for a number of drugs, such as mifepristone and misoprostol. Medical practitioners are prescribing these medications more frequently in response to the growing need for safe and effective abortion options. Pharmaceutical companies are also focusing on improving formulations and ensuring availability to improve patient outcomes. However, practical problems including limited supply and delivery networks are impeding the availability of abortion drugs.
The mifepristone segment is expected to hold the largest share of the global abortion drugs market during the projected timeframe.
Based on drug class, the global abortion drugs market is categorized as mifepristone, misoprostol, pitocin, hemabate, and carboprost. Among these, the mifepristone segment is expected to hold the largest share of the global abortion drugs market during the projected timeframe. The primary cause of this is the increasing use of mifepristone in abortion operations, frequently in conjunction with other medications. Mifepristone helps to actively stop pregnancies by softening the cervix, inhibiting progesterone, and facilitating embryo ejection.
The hospital pharmacies segment is expected to grow at the fastest CAGR during the projected timeframe.
Based on the distribution channel, the global abortion drugs market is categorized as hospital pharmacies, retail pharmacies, and online pharmacies. Among these, the hospital pharmacies segment is expected to grow at the fastest CAGR during the projected timeframe. These pharmacies provide abortion drugs like misoprostol and mifepristone while abiding by strict legal requirements and ethical standards. They actively participate in the dispensing of these medications as part of abortion procedures to ensure that patients receive the proper counseling and support.
North America is projected to hold the largest share of the global abortion drugs market over the forecast period.
Get more details on this report -
North America is projected to hold the largest share of the global abortion drugs market over the forecast period. The expansion can be ascribed to the presence of an improved healthcare system that facilitates the acquisition of prescription medications by local residents. Additionally, the role of telemedicine and online pharmacies in providing these drugs and ensuring accessibility for patients in remote areas is growing. These platforms are actively facilitating online consultations and prescription services between patients and healthcare providers.
Europe is expected to grow at the fastest CAGR growth of the global abortion drugs market during the forecast period. The expansion can be ascribed to the presence of an improved healthcare system that facilitates the acquisition of prescription medications by local residents. Additionally, the role of telemedicine and online pharmacies in providing these drugs and ensuring accessibility for patients in remote areas is growing. These platforms are actively facilitating online consultations and prescription services between patients and healthcare providers.
Major vendors in the global abortion drugs market are Cipla Limited, Endo International plc, Exelgyn, Gedeon Richter plc, Jubilant Life Sciences, Lupin Limited, Mylan N.V., Pfizer Inc., Sun Pharmaceutical Industries, Torrent Pharmaceuticals Ltd., Zydus Lifesciences Limited, and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Key Market Development
- In March 2024, in an effort to significantly expand the supply of abortion medications and potentially alter the accessibility of reproductive healthcare, CVS and Walgreens announced their plans to begin selling mifepristone.
Market Segment
- This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global abortion drugs market based on the below-mentioned segments:
Global Abortion Drugs Market, By Drug Class
- Mifepristone
- Misoprostol
- Pitocin
- Hemabate
- Carboprost
Global Abortion Drugs Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Abortion Drugs Market, By Regional
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?